On July 2, 2015, Capricor Therapeutics, Inc. accepted the resignation of Andrew Hamer, M.D., Vice President of Medical Affairs. Dr. Hamer's resignation will be effective on or about July 30, 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.07 USD | -2.88% | +7.62% | +24.13% |
05-17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
05-13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.13% | 191M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.23% | 21.58B | |
-10.97% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Capricor Therapeutics, Inc. Announces Resignation of Andrew Hamer as Vice President of Medical Affairs, Effective on or About July 30, 2015